Best-in-class growth in very difficult markets
In our 18 October note, we stated how impressed we were with Tatton’s strong net inflows during...
Read moreCore profit margin still over 30% in brutal markets
AUM fell 15% in H1-23, from £22.1bn on 1 Apr 22 to £18.8bn on 30 Sep 22. Unsurprisingly, given the...
Read moreStrong H1 with double digit revenue & profit growth
Today’s confident statement reflects a strong first half to end October 2022 (announcement...
Read more£5m biological threat-detection contract award
Kromek Group has announced the award of a three-year UK Government department biological...
Read moreNew supply chain facility progressing as planned
The Artisanal Spirits Company (ASC) continues to execute its plans to take advantage of the...
Read morePositive trading and regulatory update
RUA Life Sciences’ trading update was accompanied by a regulatory update on its vascular graft...
Read moreA sturdier foundation, with positive momentum
Management has undertaken a significant rationalisation programme, successfully commissioned new...
Read moreStrategic Update
Kinarus has announced a strategic update on the way forward: its focus (and the majority of our...
Read more